{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:07:46Z","timestamp":1773270466563,"version":"3.50.1"},"reference-count":0,"publisher":"American Psychological Association (APA)","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"am","delay-in-days":209,"URL":"http:\/\/www.apa.org\/pubs\/journals\/resources\/open-access.aspx"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["T32AA018108; K01AA023233"],"award-info":[{"award-number":["T32AA018108; K01AA023233"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","award":["K23DA052646"],"award-info":[{"award-number":["K23DA052646"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007179","name":"University of New Mexico","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007179","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Clinical Psychopharmacology"],"DOI":"10.1037\/pha0000738","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:48:20Z","timestamp":1724932100000},"page":"100-108","update-policy":"https:\/\/doi.org\/10.1037\/pha0000738","source":"Crossref","is-referenced-by-count":2,"title":["Opioid Protective Behavioral Strategies Scale (OPBSS): Development and psychometric evaluation."],"prefix":"10.1037","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9744-8551","authenticated-orcid":false,"given":"Margo C.","family":"Hurlocker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"15","published-online":{"date-parts":[[2025,2]]},"container-title":["Experimental and Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/psycnet.apa.org\/journals\/pha\/33\/1\/100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:20:26Z","timestamp":1760620826000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.apa.org\/doi\/10.1037\/pha0000738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["2025-17774-001","39207397"],"URL":"https:\/\/doi.org\/10.1037\/pha0000738","relation":{},"ISSN":["1936-2293","1064-1297"],"issn-type":[{"value":"1936-2293","type":"electronic"},{"value":"1064-1297","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}